The following funding news and opportunities were collected recently by Cancer Center Pre-Award Services and published in Cancer Center Update, a weekly e-newsletter for members and staff.

Visit the Research Funding Resources page for links to resources you can use to search for funding as well as University resources essential to application processes.

November 27

No listings were published.

November 20

Brain Tumor Society Research Grant Program
Application Deadlines: Letter of intent form due January 16, 2008. Invited full proposals due April 16, 2008.
Funding: 1-2 year, $100,000/yr direct costs. No indirect allowed.
The Brain Tumor Society seeks letters of intent for scientific research on brain tumors directed at finding a cure. Any project with the potential to advance basic scientific and translational brain tumor research will be considered. Clinical projects will not be funded. Funds may be used for startup projects or supplementary funding.

November 13

Predictive Multiscale Models of the Physiome in Health and Disease (R01)
(PAR-08-023)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Variable depending on project scope—standard NIH rules apply (<$250,000/yr direct costs—modular)
The goal of this solicitation is to move the field of biomedical computational modeling forward through the development of more realistic and predictive models of health and disease. NIH recognizes the need for sophisticated, predictive, computational models of development and disease that encompass multiple biological scales. These models may be designed to uncover biological mechanisms or to make predictions about clinical outcome and may draw on a variety of data sources including relevant clinical data.

Request for breast cancer detection pilot project applications
Friends for an Earlier Breast Cancer Test
Deadline: December 1, 2007
Applications are requested for pilot projects that focus on new methods to improve detection of early breast cancer with special interest in the development of new techniques in the areas of biological or immunologic methods of early detection. It is hoped that the pilot projects will provide preliminary data that leads to applications for more substantial peer-reviewed funding.
Applications are accepted form both established investigators who have funding but want to embark on a new area, as well as those less experienced.
Proposals should represent a new approach to the area of interest. Funds will not be given to enhance an ongoing area of research unless it is clear that a new line of inquiry is being explored. International proposals are welcome.

November 6

ELSI Regular Research Program (R01)
(PA-08-012)
ELSI Small Research Grant Program (R03)
(PA-08-013)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: R01—Variable depending on project scope. Standard NIH rules apply (<$250,000—modular); R03-up to $50,000/yr. for 2 years for a total of $100,000 direct costs over 2 years.
This FOA is designed to encourage research projects that anticipate, analyze, and address the ethical, legal, and social implications (ELSI) of the discovery and use of new information and technologies resulting from human genomic research.

Angiogenesis in the Nervous System in Health and Disease
(PA-08-015)— R01
(PA-08-016)—R21
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: R01—Variable depending on project scope. Standard NIH rules apply. (<$250,000-modular), R21—Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.

The aim of this FOA is to invite applications to study angiogenesis in the nervous system. Specific areas of research this FOA seeks to encourage include study of the mechanisms controlling angiogenic responses to physiological and pathological stimuli, the development and patterning of nervous system vasculature, and the etiology of disorders affecting development and/or ongoing angiogenesis in nervous system vasculature.

Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2008 and 2009 (P50)
(PAR-08-020)
National Cancer Institute
Application Receipt Date(s): Multiple, see announcement
Funding: New or competing renewal P50 SPORE applications may each request a maximum annual total cost of $2.5 million. The overhead costs related to subcontracts to other institutions or organizations are included in the total cost cap of $2.5 million. Applications can exceed this cap in subsequent years as a result of standard cost-of-living increases or special supplements approved by NCI.

As defined and supported by the NCI, a Specialized Program of Research Excellence (SPORE) conducts state-of-the-art research that will contribute to improved screening, detection, diagnosis, treatment, and prevention of an organ-specific cancer (or related group of cancers). SPOREs are expected not only to conduct a wide spectrum of research activities, but should also contribute significantly to the development of specialized research cores, improved research model systems, and collaborative research projects with other institutions. The research supported through this program must be translational in nature.

Anemia of Inflammation and of Chronic Diseases (R01)
(PAS-08-019)
National Cancer Institute, National Heart, Lung, and Blood Institute, National Institute on Aging
Application Receipt Date(s): Multiple, see announcement.
Funding: Depending on project scope, standard NIH rules apply (<$250,000 —modular)

The goal of this announcement is to encourage R01 grant applications that propose research on anemia caused by inflammation or by chronic diseases (AICD).  Such research should develop a better understanding of the pathophysiology and clinical impact of AICD and lead to improvements in the detection, prevention and treatment of this common form of anemia.

Nanomedicine funding opportunity
NCI Division of Cancer Biology
Deadline: Letter of Interest in Collaboration, December 10, 2007
Invited Application Receipt Date: Mar 24, 2008
Earliest Anticipated Start Date: May, 2008
The network of NIH Nanomedicine Development Centers requests letters from clinical investigators interested in collaborating in the nanomedicine research enterprise. Clinical investigators, with ongoing preclinical/translational research programs, will be expected to participate in the activities of one or more of the NIH Nanomedicine Development Centers (NDC) and to explore opportunities for potential medical applications that build on the science emerging from one or more of the centers. Approximately $2,000,000 annually for two years will be available to support three to five projects from clinical collaborators.

Further information on the LIC application process is available at the Web site. For more information contact, Dan Gallahan, Ph.D., Deputy Director, Division of Cancer Biology, NCI , 301-496-8636, dg13w@nih.gov.

Doctors Cancer Foundation
Application Receipt Date: December 31, 2008
Funding: Two $50,000 grants
The Doctors Cancer Foundation is offering two grants for cancer research. The first grant is for the best genetic or epigenetic program for the management of any kind of cancer. The second grant will be a Nolan Miller grant of $50,000 for the best genetic or epigenetic program for the management of lung cancer. Applications should be as concise as possible with a maximum of 10 pages. The reviewers are practicing physicians. Completed applications should be emails to dcf@doctorscancerfoundation.org. The awards will be announced in May 2008. Visit the Web site for more information.